252 related articles for article (PubMed ID: 21310826)
21. Prognostic significance of CDKN2A (p16) promoter methylation and loss of expression in 902 colorectal cancers: Cohort study and literature review.
Shima K; Nosho K; Baba Y; Cantor M; Meyerhardt JA; Giovannucci EL; Fuchs CS; Ogino S
Int J Cancer; 2011 Mar; 128(5):1080-94. PubMed ID: 20473920
[TBL] [Abstract][Full Text] [Related]
22. Epigenomic diversity of colorectal cancer indicated by LINE-1 methylation in a database of 869 tumors.
Baba Y; Huttenhower C; Nosho K; Tanaka N; Shima K; Hazra A; Schernhammer ES; Hunter DJ; Giovannucci EL; Fuchs CS; Ogino S
Mol Cancer; 2010 May; 9():125. PubMed ID: 20507599
[TBL] [Abstract][Full Text] [Related]
23. CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer.
Ogino S; Nosho K; Kirkner GJ; Kawasaki T; Meyerhardt JA; Loda M; Giovannucci EL; Fuchs CS
Gut; 2009 Jan; 58(1):90-6. PubMed ID: 18832519
[TBL] [Abstract][Full Text] [Related]
24. Prognostic significance of AMP-activated protein kinase expression and modifying effect of MAPK3/1 in colorectal cancer.
Baba Y; Nosho K; Shima K; Meyerhardt JA; Chan AT; Engelman JA; Cantley LC; Loda M; Giovannucci E; Fuchs CS; Ogino S
Br J Cancer; 2010 Sep; 103(7):1025-33. PubMed ID: 20808308
[TBL] [Abstract][Full Text] [Related]
25. Comprehensive biostatistical analysis of CpG island methylator phenotype in colorectal cancer using a large population-based sample.
Nosho K; Irahara N; Shima K; Kure S; Kirkner GJ; Schernhammer ES; Hazra A; Hunter DJ; Quackenbush J; Spiegelman D; Giovannucci EL; Fuchs CS; Ogino S
PLoS One; 2008; 3(11):e3698. PubMed ID: 19002263
[TBL] [Abstract][Full Text] [Related]
26. PIK3CA and PTEN gene and exon mutation-specific clinicopathologic and molecular associations in colorectal cancer.
Day FL; Jorissen RN; Lipton L; Mouradov D; Sakthianandeswaren A; Christie M; Li S; Tsui C; Tie J; Desai J; Xu ZZ; Molloy P; Whitehall V; Leggett BA; Jones IT; McLaughlin S; Ward RL; Hawkins NJ; Ruszkiewicz AR; Moore J; Busam D; Zhao Q; Strausberg RL; Gibbs P; Sieber OM
Clin Cancer Res; 2013 Jun; 19(12):3285-96. PubMed ID: 23633456
[TBL] [Abstract][Full Text] [Related]
27. Colorectal cancer molecular classification using BRAF, KRAS, microsatellite instability and CIMP status: Prognostic implications and response to chemotherapy.
Murcia O; Juárez M; Rodríguez-Soler M; Hernández-Illán E; Giner-Calabuig M; Alustiza M; Egoavil C; Castillejo A; Alenda C; Barberá V; Mangas-Sanjuan C; Yuste A; Bujanda L; Clofent J; Andreu M; Castells A; Llor X; Zapater P; Jover R
PLoS One; 2018; 13(9):e0203051. PubMed ID: 30188916
[TBL] [Abstract][Full Text] [Related]
28. The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer.
Goel A; Nagasaka T; Arnold CN; Inoue T; Hamilton C; Niedzwiecki D; Compton C; Mayer RJ; Goldberg R; Bertagnolli MM; Boland CR
Gastroenterology; 2007 Jan; 132(1):127-38. PubMed ID: 17087942
[TBL] [Abstract][Full Text] [Related]
29. Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis.
Mima K; Nishihara R; Qian ZR; Cao Y; Sukawa Y; Nowak JA; Yang J; Dou R; Masugi Y; Song M; Kostic AD; Giannakis M; Bullman S; Milner DA; Baba H; Giovannucci EL; Garraway LA; Freeman GJ; Dranoff G; Garrett WS; Huttenhower C; Meyerson M; Meyerhardt JA; Chan AT; Fuchs CS; Ogino S
Gut; 2016 Dec; 65(12):1973-1980. PubMed ID: 26311717
[TBL] [Abstract][Full Text] [Related]
30. Colorectal cancer expression of peroxisome proliferator-activated receptor gamma (PPARG, PPARgamma) is associated with good prognosis.
Ogino S; Shima K; Baba Y; Nosho K; Irahara N; Kure S; Chen L; Toyoda S; Kirkner GJ; Wang YL; Giovannucci EL; Fuchs CS
Gastroenterology; 2009 Apr; 136(4):1242-50. PubMed ID: 19186181
[TBL] [Abstract][Full Text] [Related]
31. Correlation of beta-catenin localization with cyclooxygenase-2 expression and CpG island methylator phenotype (CIMP) in colorectal cancer.
Kawasaki T; Nosho K; Ohnishi M; Suemoto Y; Kirkner GJ; Dehari R; Meyerhardt JA; Fuchs CS; Ogino S
Neoplasia; 2007 Jul; 9(7):569-77. PubMed ID: 17710160
[TBL] [Abstract][Full Text] [Related]
32. CpG island methylator phenotype in colorectal cancers: comparison of the new and classic CpG island methylator phenotype marker panels.
Lee S; Cho NY; Yoo EJ; Kim JH; Kang GH
Arch Pathol Lab Med; 2008 Oct; 132(10):1657-65. PubMed ID: 18834226
[TBL] [Abstract][Full Text] [Related]
33. Fatty acid synthase overexpression in colorectal cancer is associated with microsatellite instability, independent of CpG island methylator phenotype.
Ogino S; Kawasaki T; Ogawa A; Kirkner GJ; Loda M; Fuchs CS
Hum Pathol; 2007 Jun; 38(6):842-9. PubMed ID: 17350669
[TBL] [Abstract][Full Text] [Related]
34. Molecular correlates with MGMT promoter methylation and silencing support CpG island methylator phenotype-low (CIMP-low) in colorectal cancer.
Ogino S; Kawasaki T; Kirkner GJ; Suemoto Y; Meyerhardt JA; Fuchs CS
Gut; 2007 Nov; 56(11):1564-71. PubMed ID: 17339237
[TBL] [Abstract][Full Text] [Related]
35. A cohort study of STMN1 expression in colorectal cancer: body mass index and prognosis.
Ogino S; Nosho K; Baba Y; Kure S; Shima K; Irahara N; Toyoda S; Chen L; Kirkner GJ; Wolpin BM; Chan AT; Giovannucci EL; Fuchs CS
Am J Gastroenterol; 2009 Aug; 104(8):2047-56. PubMed ID: 19513025
[TBL] [Abstract][Full Text] [Related]
36. Negative lymph node count is associated with survival of colorectal cancer patients, independent of tumoral molecular alterations and lymphocytic reaction.
Ogino S; Nosho K; Irahara N; Shima K; Baba Y; Kirkner GJ; Mino-Kenudson M; Giovannucci EL; Meyerhardt JA; Fuchs CS
Am J Gastroenterol; 2010 Feb; 105(2):420-33. PubMed ID: 19809407
[TBL] [Abstract][Full Text] [Related]
37. Combined analysis of COX-2 and p53 expressions reveals synergistic inverse correlations with microsatellite instability and CpG island methylator phenotype in colorectal cancer.
Ogino S; Brahmandam M; Kawasaki T; Kirkner GJ; Loda M; Fuchs CS
Neoplasia; 2006 Jun; 8(6):458-64. PubMed ID: 16820091
[TBL] [Abstract][Full Text] [Related]
38. Loss of CDX2/CK20 expression is associated with poorly differentiated carcinoma, the CpG island methylator phenotype, and adverse prognosis in microsatellite-unstable colorectal cancer.
Kim JH; Rhee YY; Bae JM; Cho NY; Kang GH
Am J Surg Pathol; 2013 Oct; 37(10):1532-41. PubMed ID: 24025523
[TBL] [Abstract][Full Text] [Related]
39. TGFBR2 mutation is correlated with CpG island methylator phenotype in microsatellite instability-high colorectal cancer.
Ogino S; Kawasaki T; Ogawa A; Kirkner GJ; Loda M; Fuchs CS
Hum Pathol; 2007 Apr; 38(4):614-20. PubMed ID: 17270239
[TBL] [Abstract][Full Text] [Related]
40. Prognostic Utility of Molecular Factors by Age at Diagnosis of Colorectal Cancer.
McCleary NJ; Sato K; Nishihara R; Inamura K; Morikawa T; Zhang X; Wu K; Yamauchi M; Kim SA; Sukawa Y; Mima K; Qian ZR; Fuchs CS; Ogino S; Meyerhardt JA
Clin Cancer Res; 2016 Mar; 22(6):1489-98. PubMed ID: 26490308
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
